|
Clinical Presentation of Anthrax
Cutaneous Anthrax
More than 95% of cases of anthrax worldwide are cutaneous (Figure 1).
After anthrax spores enter the body, the incubation period is 1 to 5 days.
The disease first appears as a small papule, or growth, that progresses over a
day or two to a blister containing serosanguinous fluid (clear mixed with small
amounts of blood) with few white blood cells (puss or leukocytes). The blister,
which may be 1 to 2 cm in diameter, ruptures, leaving a necrotic ulcer.
Satellite blister may also be present. The lesion is usually painless, and
varying degrees of edema (swelling) may be present around it. The edema may
occasionally be massive, encompassing the entire face or limb, and is described
by the term “malignant edema.” Patients usually have fever, malaise
(fatigue), and headache, which may be severe in those with extensive edema.
There may also be local swelling and tenderness of the lymphnodes
(lymphadenitis). The ulcer base develops a characteristic black scab
(eschar) and after a period of 2 to 3 weeks the scab separates, often leaving a
scar. Shock due to bacteria in the blood (septicemia) is very rare, and
with treatment mortality should be less than 1%.
A.
B.
Fig. 1. (a) Cutaneous lesion of anthrax demonstrating eschar
(scab) and edema (swelling) in a man, following his handling of a contaminated
cow carcass in a rendering plant in Colorado. (b) Cutaneous lesion of anthrax
with eschar (on the patient’s neck), on approximately day 15 of disease. The
patient had worked with air-dried goat skins from Africa. Photograph A:
Courtesy of Arnold Kaufmann, Ph.D., National Center for Infectious Disease,
Centers for Disease and Control and Prevention, Atlanta, Ga. Photograph B:
Reprinted from Binford CH, Connor DH, eds. Pathology of Tropical and
Extraordinary Diseases. Vol 1. Washington, DC: Armed Forces Institute of
Pathology; 1976: 121. AFIP Negative 75-4203-7.
Inhalational Anthrax
Inhalational anthrax begins after an incubation period of 1 to 6 days with
nonspecific symptoms of fatigue, muscle pains (myalgia), and fever. There
may be an associated nonproductive cough and mild chest discomfort. These
symptoms usually persist for 2 or 3 days, and in some cases there may be a short
period of improvement. This is followed by the sudden onset of increasing
respiratory distress with shortness of breath (dyspnea), difficulty breathing
(stridor), insufficient oxygenation (cyanosis), increased chest pain, and
sweating (diaphoresis). There may be associated edema (swelling) of the
chest and neck.
Chest X-ray examination usually shows the characteristic widening of the
mediastinum and, often, pleural effusions (fluid collecting around the lung)
(Figure 2). Pneumonia has not been a consistent finding but can occur in
some patients1. While cases of inhalational anthrax have been rare in
this century, several have occurred in patients with underlying pulmonary
disease, suggesting that this condition may increase susceptibility to the
disease2. Meningitis is present in up to 50% of cases, and some
patients may present with seizures. The onset of respiratory distress is
followed by the rapid onset of shock and death within 24 to 36 hours.
Mortality has been essentially 100% despite appropriate treatment.

Fig. 2. This x-ray, taken on day 2 of illness, shows the lungs of a
51-year-old laborer with occupational exposure to airborne anthrax spores.
Marked mediastinal widening is evident, with a small parenchymal infiltrate.
Reprinted from Binford CH, Connor DH, eds. Pathology of Tropical and
Extraordinary Diseases. Vol 1. Washington, DC: Armed Forces Institute of
Pathology; 1976: 119. AFIP Negative 71-1290-2.
Oropharyngeal and Gastrointestinal Anthrax
Oropharyngeal and gastrointestinal anthrax result from the ingestion of
infected meat that has not been sufficiently cooked. After an incubation period
of 2 to 5 days, patients with oropharyngeal disease present with severe sore
throat or a local oral or tonsillar ulcer, usually associated with fever,
toxicity, and swelling of the neck due to cervical or swelling of the lymphnodes
in the neck area (submandibular lymphadenitis) and edema. Difficulty swallowing
(dysphagia) and respiratory distress may also be present. Gastrointestinal
anthrax begins with nonspecific symptoms of nausea, vomiting, and fever; these
are followed in most cases by severe abdominal pain. The presenting sign may be
an acute abdomen, which may be associated with vomiting blood (hematemesis),
fluid in the abdominal cavity (massive ascites), and diarrhea. Mortality in both
forms may be as high as 50%, especially in the gastrointestinal form.
Meningitis
Meningitis may occur following bacteremia (bacteria in the blood), as a
complication of any of the other clinical forms of the disease. Meningitis may
also occur, very rarely, without a clinically apparent primary focus. It is very
often hemorrhagic, which is important diagnostically, and almost invariably
fatal (Figure 3).

Fig. 3. Meningitis with subarachnoid hemorrhage in a man from Thailand
who died 5 days after eating undercooked carabao (water buffalo). Reprinted from
Binford CH, Connor DH, eds. Pathology of Tropical and Extraordinary Diseases.
Vol 1. Washington, DC: Armed Forces Institute of Pathology; 1976: 121. AFIP
Negative 75-12374-3.
_________________
1. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. Pathology of
inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl
Acad Sci U S A. 1993;90:2291–2294.
2. Brachman PS. Inhalation anthrax. Ann N Y Acad Sci. 1980;353:83–93.
(The above material
has been derived from the U.S. Navy's Virtual Naval Hospital web site
www.vnh.org)
[to top]]
|
|
|